# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The U.S. Food and Drug Administration (FDA) is set to launch a pilot program to fast-track the review of nicotine pouches from ...
Defiance ETFs launches ZYN, a 2X leveraged Philip Morris ETF offering amplified exposure to its smoke-free transition.